Furthermore, many TFs, such as FOXA1 and ESR1, have been shown to contribute oncogenic activity in some cancer types, while acting as tumour suppressors in other contexts, often involving different protein–protein interactions49,50. This evidence concerns the gene FOXA1 and neoplasm.